rs4899145

Variant summary

Our verdict is Benign. The variant received -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BA1

The NM_001355436.2(SPTB):​c.4818C>T​(p.Tyr1606Tyr) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0718 in 1,613,884 control chromosomes in the GnomAD database, including 4,602 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).

Frequency

Genomes: 𝑓 0.059 ( 296 hom., cov: 32)
Exomes 𝑓: 0.073 ( 4306 hom. )

Consequence

SPTB
NM_001355436.2 synonymous

Scores

2

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:6

Conservation

PhyloP100: -0.0440

Publications

14 publications found
Variant links:
Genes affected
SPTB (HGNC:11274): (spectrin beta, erythrocytic) This locus encodes a member of the spectrin gene family. Spectrin proteins, along with ankyrin, play a role in cell membrane organization and stability. The protein encoded by this locus functions in stability of erythrocyte membranes, and mutations in this gene have been associated with spherocytosis type 2, hereditary elliptocytosis, and neonatal hemolytic anemia. Alternatively spliced transcript variants have been described. [provided by RefSeq, Nov 2009]
SPTB Gene-Disease associations (from GenCC):
  • hereditary spherocytosis type 2
    Inheritance: AD Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae)
  • elliptocytosis 3
    Inheritance: AR Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae)
  • hereditary elliptocytosis
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • hereditary spherocytosis
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -21 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.53).
BP6
Variant 14-64775149-G-A is Benign according to our data. Variant chr14-64775149-G-A is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 257127.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=-0.044 with no splicing effect.
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.0829 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
SPTBNM_001355436.2 linkc.4818C>T p.Tyr1606Tyr synonymous_variant Exon 23 of 36 ENST00000644917.1 NP_001342365.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
SPTBENST00000644917.1 linkc.4818C>T p.Tyr1606Tyr synonymous_variant Exon 23 of 36 NM_001355436.2 ENSP00000495909.1
SPTBENST00000553938.5 linkc.813C>T p.Tyr271Tyr synonymous_variant Exon 4 of 18 1 ENSP00000451324.1
SPTBENST00000389722.7 linkc.4818C>T p.Tyr1606Tyr synonymous_variant Exon 22 of 35 2 ENSP00000374372.3
SPTBENST00000389720.4 linkc.4818C>T p.Tyr1606Tyr synonymous_variant Exon 23 of 32 5 ENSP00000374370.4

Frequencies

GnomAD3 genomes
AF:
0.0585
AC:
8910
AN:
152180
Hom.:
296
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0224
Gnomad AMI
AF:
0.0515
Gnomad AMR
AF:
0.0536
Gnomad ASJ
AF:
0.0550
Gnomad EAS
AF:
0.0196
Gnomad SAS
AF:
0.0286
Gnomad FIN
AF:
0.0767
Gnomad MID
AF:
0.0443
Gnomad NFE
AF:
0.0847
Gnomad OTH
AF:
0.0440
GnomAD2 exomes
AF:
0.0607
AC:
15211
AN:
250798
AF XY:
0.0610
show subpopulations
Gnomad AFR exome
AF:
0.0201
Gnomad AMR exome
AF:
0.0411
Gnomad ASJ exome
AF:
0.0505
Gnomad EAS exome
AF:
0.0261
Gnomad FIN exome
AF:
0.0762
Gnomad NFE exome
AF:
0.0842
Gnomad OTH exome
AF:
0.0603
GnomAD4 exome
AF:
0.0731
AC:
106893
AN:
1461586
Hom.:
4306
Cov.:
33
AF XY:
0.0722
AC XY:
52530
AN XY:
727114
show subpopulations
African (AFR)
AF:
0.0184
AC:
615
AN:
33480
American (AMR)
AF:
0.0440
AC:
1966
AN:
44724
Ashkenazi Jewish (ASJ)
AF:
0.0518
AC:
1355
AN:
26136
East Asian (EAS)
AF:
0.0165
AC:
657
AN:
39700
South Asian (SAS)
AF:
0.0303
AC:
2611
AN:
86258
European-Finnish (FIN)
AF:
0.0786
AC:
4179
AN:
53150
Middle Eastern (MID)
AF:
0.0392
AC:
226
AN:
5768
European-Non Finnish (NFE)
AF:
0.0821
AC:
91282
AN:
1111980
Other (OTH)
AF:
0.0663
AC:
4002
AN:
60390
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.451
Heterozygous variant carriers
0
6179
12358
18537
24716
30895
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
3192
6384
9576
12768
15960
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0585
AC:
8912
AN:
152298
Hom.:
296
Cov.:
32
AF XY:
0.0585
AC XY:
4354
AN XY:
74460
show subpopulations
African (AFR)
AF:
0.0224
AC:
932
AN:
41568
American (AMR)
AF:
0.0536
AC:
820
AN:
15306
Ashkenazi Jewish (ASJ)
AF:
0.0550
AC:
191
AN:
3470
East Asian (EAS)
AF:
0.0197
AC:
102
AN:
5186
South Asian (SAS)
AF:
0.0284
AC:
137
AN:
4822
European-Finnish (FIN)
AF:
0.0767
AC:
814
AN:
10608
Middle Eastern (MID)
AF:
0.0442
AC:
13
AN:
294
European-Non Finnish (NFE)
AF:
0.0847
AC:
5763
AN:
68020
Other (OTH)
AF:
0.0440
AC:
93
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.500
Heterozygous variant carriers
0
454
908
1363
1817
2271
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
102
204
306
408
510
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0740
Hom.:
999
Bravo
AF:
0.0544
Asia WGS
AF:
0.0580
AC:
201
AN:
3478
EpiCase
AF:
0.0759
EpiControl
AF:
0.0763

ClinVar

Significance: Benign/Likely benign
Submissions summary: Benign:6
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:3
Nov 25, 2024
ARUP Laboratories, Molecular Genetics and Genomics, ARUP Laboratories
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Jan 27, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Breakthrough Genomics, Breakthrough Genomics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

not specified Benign:1
-
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Elliptocytosis Benign:1
Jun 14, 2016
Illumina Laboratory Services, Illumina
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Spherocytosis, Dominant Benign:1
Jun 14, 2016
Illumina Laboratory Services, Illumina
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.53
CADD
Benign
1.8
DANN
Benign
0.25
PhyloP100
-0.044
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.8
Mutation Taster
=99/1
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs4899145; hg19: chr14-65241867; COSMIC: COSV107501389; API